These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10767789)

  • 21. Role of platelet-derived growth factor in obliterative bronchiolitis (chronic rejection) in the rat.
    Kallio EA; Koskinen PK; Aavik E; Buchdunger E; Lemström KB
    Am J Respir Crit Care Med; 1999 Oct; 160(4):1324-32. PubMed ID: 10508825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy.
    Tambur AR; Pamboukian S; Costanzo MR; Heroux A
    J Heart Lung Transplant; 2006 Jun; 25(6):690-8. PubMed ID: 16730575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression and regression of myointimal hyperplasia in experimental vein grafts depends on platelet-derived growth factor and basic fibroblastic growth factor production.
    Sterpetti AV; Cucina A; Lepidi S; Randone B; Stipa F; Aromatario C; Travi D; D'Angelo LS; Cavallaro A; Stipa S
    J Vasc Surg; 1996 Apr; 23(4):568-75. PubMed ID: 8627890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PDGF-A, -C, and -D but not PDGF-B increase TGF-beta1 and chronic rejection in rat cardiac allografts.
    Tuuminen R; Nykänen AI; Krebs R; Soronen J; Pajusola K; Keränen MA; Koskinen PK; Alitalo K; Lemström KB
    Arterioscler Thromb Vasc Biol; 2009 May; 29(5):691-8. PubMed ID: 19213942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular effects of cyclosporin A and acute rejection in canine heart transplantation.
    Bouchard D; Despatis MA; Buluran J; Cartier R
    Ann Thorac Surg; 1997 Nov; 64(5):1325-30. PubMed ID: 9386698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antisense extracellular signal-regulated kinase-2 gene therapy inhibits platelet-derived growth factor-induced proliferation, migration and transforming growth factor-beta(1) expression in vascular smooth muscle cells and attenuates transplant vasculopathy.
    Chen XL; Chen ZS; Ding Z; Dong C; Guo H; Gong NQ
    Transpl Int; 2008 Jan; 21(1):30-8. PubMed ID: 17927678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin and local growth factor PDGF induce intimal hyperplasia in bypass graft culture models of saphenous vein and internal mammary artery.
    Huang B; Dreyer T; Heidt M; Yu JC; Philipp M; Hehrlein FW; Katz N; Al-Fakhri N
    Eur J Cardiothorac Surg; 2002 Jun; 21(6):1002-8. PubMed ID: 12048077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen effects on insulin-like growth factor-I (IGF-I)-induced cell proliferation and IGF-I expression in native and allograft vessels.
    Lou H; Zhao Y; Delafontaine P; Kodama T; Katz N; Ramwell PW; Foegh ML
    Circulation; 1997 Aug; 96(3):927-33. PubMed ID: 9264503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The angiotensin II type 1 receptor blocker candesartan attenuates graft vasculopathy.
    Yamamoto T; Sata M; Fukuda D; Takamoto S
    J Surg Res; 2006 May; 132(1):62-8. PubMed ID: 16140337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study.
    Mehra MR; Ventura HO; Chambers R; Collins TJ; Ramee SR; Kates MA; Smart FW; Stapleton DD
    J Am Coll Cardiol; 1995 Nov; 26(6):1537-44. PubMed ID: 7594082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of wild-type P53 gene transfer on graft coronary artery disease.
    Wang LP; Jia ZB; Liu Y; Gao Q; Cheng SJ; Jin D; Ma L; Yin XH
    Transpl Immunol; 2018 Jun; 48():1-9. PubMed ID: 29425775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transplant arterial vasculopathy: evidence for a dual pattern of endothelial injury and the source of smooth muscle cells in lesions of intimal hyperplasia.
    Aziz S; McDonald TO; Gohra H
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S123-36. PubMed ID: 8719474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of aortic allograft vasculopathy by local delivery of platelet-derived growth factor receptor tyrosine-kinase blocker AG-1295.
    Karck M; Meliss R; Hestermann M; Mengel M; Pethig K; Levitzki A; Banai S; Golomb G; Fishbein I; Chorny M; Haverich A
    Transplantation; 2002 Nov; 74(9):1335-41. PubMed ID: 12451275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary venous intimal thickening in explanted cardiac allografts. Evidence demonstrating that transplant coronary artery disease is a manifestation of a diffuse allograft vasculopathy.
    Oni AA; Ray J; Hosenpud JD
    Transplantation; 1992 Jun; 53(6):1247-51. PubMed ID: 1604479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral Platelet-Derived Growth Factor and Vascular Endothelial Growth Factor Inhibitor Sunitinib Prevents Chronic Allograft Injury in Experimental Kidney Transplantation Model.
    Rintala JM; Savikko J; Palin N; Rintala SE; Koskinen PK; von Willebrand E
    Transplantation; 2016 Jan; 100(1):103-10. PubMed ID: 26262503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased production of cytokines and growth factors by aortic allografts: A possible explanation for myointimal hyperplasia formation.
    Sterpetti AV; Cucina A; Randone B; Guglielmi MB; Fragale A; Cavallaro A
    Eur Surg Res; 1999; 31(4):297-304. PubMed ID: 10449988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-derived growth factor rather than basic fibroblast growth factor and vascular endothelial cell growth factor is involved in adventitial narrowing causing vascular stenosis in end-stage cardiac allograft vasculopathy.
    Meliss RR; Pethig K; Steinhoff G; Harringer W; Heublein B; Choritz H; Haverich A
    Transplant Proc; 1999; 31(1-2):89-90. PubMed ID: 10083020
    [No Abstract]   [Full Text] [Related]  

  • 38. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
    Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
    Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation.
    Chang Y; Ceacareanu B; Zhuang D; Zhang C; Pu Q; Ceacareanu AC; Hassid A
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):501-7. PubMed ID: 16373608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of platelet derived growth factor in endomyocardial biopsies shortly after heart transplantation in relation to postoperative course.
    Sack FU; Vielfort TJ; Koch A; Haass M; Taylor S; Otto HF; Hagl S; Schnabel PA
    Eur J Cardiothorac Surg; 2004 Jan; 25(1):91-7. PubMed ID: 14690738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.